6 курс / Кардиология / Джон_Кэмм_Болезни_сердца_и_сосудов_2011
.pdf310.Bellandi F., Simonetti I., Leoncini M. et al. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation // Am. J. Cardiol. - 2001. - Vol. 88. - P. 640-645.
311.Roy D., Talajic M., Dorian P. et al. - for the Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation // N. Engl. J. Med. - 2000. - Vol. 342. - P. 913-920.
312.The AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM Substudy of First Antiarrhythmic Drug // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 20-29.
313.Torp-Pedersen C., Møller M., Bloch-Thomsen P.E. et al. - for the Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. Dofetilide in patients with congestive heart failure and left ventricular dysfunction // N. Engl. J. Med. - 1999. - Vol. 341. -
P. 857-865.
314.Køber L., Bloch Thomsen P.E., Møller M. et al. - Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial // Lancet. - 2000. - Vol. 356. - P. 2052-2058.
315.Boutitie F, Boissel JP, Connolly SJ, et al. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators // Circulation. - 1999. - Vol. 99. - P. 2268-2275.
316.Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) // Lancet. - 1994. - Vol. 344. - P. 493-498.
317.Touboul P, Brugada J, Capucci A, et al. Dronedarone for prevention of atrial fibrillation: a doseranging study // Eur. Heart J. - 2003. - Vol. 24. - P. 1481-1487.
318.Singh BN, Connolly SJ, Crijns HJ, et al. - EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter // N. Engl. J. Med. - 2007. - Vol. 357. - P. 987999.
319.Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation // N. Engl. J. Med. - 2009. - Vol. 360. - P. 668-678.
320.Køber L., Torp-Pedersen C., McMurray J.J. et al. - Dronedarone Study Group. Increased mortality after dronedarone therapy for severe heart failure // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2678-2687.
321.Sung R.J. Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic // Drugs: update on clinical trial results // Card. Electrophysiol. Rev. - 2003. - Vol. 7. - P. 300-303.
322.Oral H., Souza J.J., Michand G.F. et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment // N. Engl. J. Med. - 1999. - Vol. 340. - P. 1849-1854.
323.Boriani J., Biffi M., Capucci A. et al. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation // J. Am. Coll. Cardiol. - 1999. - Vol. 33. - P. 333-341.
324.Tse H.F., Lau C.P., Ayers G.M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol // Heart. - 1999. - Vol. 82.
-
P. 319-324.
325.Capucci A., Villani G.Q., Aschieri D. et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation // Eur. Heart J. - 2000. - Vol. 21. - P. 66-73.
326.Bianconi L., Mennuni M., Lukic V. et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study // J. Am. Coll. Cardiol. - 1996. -
Vol. 28. - P. 700-706.
327.De Simone A., De Pasquale M., De Matteis C. et al. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study) // Eur. Heart J. - 2003. -
Vol. 24. - P. 1425-1429.
328.Ahmed S., Rienstra M., Crijns H.J. et al. - CONVERT Investigators. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial // JAMA. - 2008. - Vol. 300. - P. 1784-1792.
329.Cappato R., Calkins H., Chen S.A. et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation // Circulation. - 2005. - Vol. 111. - P. 1100-1105.
330.Khan I.A., Nair C.K., Singh N. et al. Acute ventricular rate control in atrial fibrillation and atrial flutter // Int. J. Cardiol. - 2004. - Vol. 97. - P. 7-13.
331.Clemo H.F., Wood M.A., Gilligan D.M. et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias // Am. J. Cardiol. - 1998. - Vol. 81. - P. 594-598.
332.Thomas S.P., Guy D., Wallace E. et al. Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial // Am. Heart J. - 2004. -
Vol. 147: e3.
333.Simpson C.S., Ghali W.A., Sanfilippo A.J. et al. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial // Am. Heart J. - 2001. - Vol. 142: e3.
334.Ellenbogen K.A., O’Neill G., Prystowsky E.N. et al. - TEMPEST Study Group. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson // Circulation. - 2005. - Vol. 111. - P. 3202-3208.
335.Murgatroyd F.D., Gibson S.M., Baiyan X. et al., for the Controlled Randomized Atrial Fibrillation Trial (CRAFT) Investigators. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation // Circulation. - 1999. - Vol. 99. - P. 2765-2770.
336.Brodsky M., Saini R., Bellinger R. et al. Comparative effects of the combination of digoxin and dlsotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation: dl-Sotalol Atrial Fibrillation Study Group // Am. Heart J. - 1994. - Vol. 127. - P. 572-577.
337.Kochiadakis G.E., Kanoupakis E.M., Kalebubas M.D. et al. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study // Euro PACE. - 2001. - Vol. 3. - P. 73-79.
338.Davy J.M., Herold M., Hoglund C. et al. - ERATO Study Investigators. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study // Am. Heart J. - 2008. - Vol. 156. - P. 527. - e1-9.
339.Rawles J.M. What is meant by a ‘controlled’ventricular rate in atrial fibrillation? // Br. Heart J. - 1990. - Vol. 63. - P. 157-161.
340.Van Gelder I.C., Wyse D.G., Chandler M.L. et al. - RACE and AFFIRM Investigators. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies // Euro PACE. - 2006. - Vol. 8. - P. 935-942.
341.Daoud E.G., Weiss R., Bahu M. et al. Effect of an irregular ventricular rhythm on cardiac output // Am. J. Cardiol. - 1996. - Vol. 78. - P. 1433-1436.
342.Van Gelder I.C., Van Veldhuisen D.J., Crijns H.J. et al. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II // Am. Heart J. - 2006. - Vol. 152. - P. 420-426.
343.Olshansky B., Rosenfeld L.E., Warner A.L. et al. - AFFIRM Investigators. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1201-1208.
344.Farshi R., Kistner D., Sarma J.S. et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens // J. Am. Coll. Cardiol. - 1999. - Vol. 33. - P. 304-310.
345.Khand A.U., Rankin A.C., Martin W. et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? // J. Am. Coll. Cardiol. - 2003. - Vol. 42. -
P. 1944-1951.
346.Mitchell L.B., Crystal E., Heilbron B. et al. Atrial fibrillation following cardiac surgery // Can. J. Cardiol. - 2005. - Vol. 21. (Suppl B). -
P. 45B-50B.
347.Kowey P.R., Taylor J.E., Rials S.J. et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting // Am. J. Cardiol. - 1992. - Vol. 69. - P. 963-965.
348.Andrews T.C., Reimold S.C., Berlin J.A. et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized trials // Circulation. - 1991. -
Vol. 84. (Suppl III): III-236-III-244.
349.Mitchell L.B., Exner D.V., Wyse D.G. et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial // JAMA. - 2005. - Vol. 294. - P. 3093-3100.
350.Patti G., Chello M., Candura D. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3. (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study // Circulation. - 2006. - Vol. 114. -
P. 1455-1461.
351.Halonen J., Halonen P., Jarvinen O. et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial // JAMA. - 2007. - Vol. 297. - P. 1562-1567.
352.Calo L., Bianconi L., Colivicchi F. et al. n-3. Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial // J. Am. Coll. Cardiol. - 2005. - Vol. 45. -
P. 1723-1728.
353.Savelieva I., Camm J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation // Nat. Clin. Prac.t Cardiovasc. Med. - 2008. - Vol. 5. - P. 30-41.
354.Kourliouros A., Savelieva I., Jahangiri M. et al. Current concepts in the pathogenesis of atrial fibrillation // Am. Heart J. - 2009. - Vol. 157. - P. 243-252.
355.Fauchier L., Pierre B., de Labriolle A. et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 828-835.
356.Lown B., Perlroth M.G., Kaidbey S. et al. ‘Cardioversion’ of atrial fibrillation. A report on the treatment of 65. episodes in 50. patients // N. Engl. J. Med. - 1963. - Vol. 269. - P. 325-331.
357.Botto G.L., Politi A., Bonini W. et al. External cardioversion: role of paddle position on technical efficacy and energy requirements // Heart. - 1999. - Vol. 82. - P. 726-730.
358.Alp N.J., Rahman S., Bell J.A. et al. Randomised comparison of antero-lateral versus anteroposterior paddle positions for DC cardioversion of persistent atrial fibrillation // Int. J. Cardiol. - 2000. - Vol. 75. - P. 211-216.
359.Kirchhof P., Eckardt L., Loh P. et al. Antero-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial // Lancet. - 2002. - Vol. 360. - P. 1275-1279.
360.Van Gelder I.C., Crijns H.J., Gilst W.H. et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter // Am. J. Cardiol. - 1991. - Vol. 68. - P. 41-46.
361.Elhendy A., Gentile F., Khandheria B.K. et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation // Am. J. Cardiol. - 2002. - Vol. 89. - P. 83-86.
362.Mittal S., Ayati S., Stein K.M. et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks // Circulation. - 2000. - Vol. 101. - P. 1282-1287.
363.Ricard P., Levy S., Boccara G. et al. External cardioversion of atrial fibrillation: comparison of biphasic versus monophasic waveform shocks // Euro PACE. - 2001. - Vol. 3. - P. 96-99.
364.Page R.L., Kerber R.E., Russell J.K. et al., for the BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation // J. Am. Coll. Cardiol. - 2002. - Vol. 39. - P. 1956-1963.
365.Lévy, S., Lauribe P., Dolla E. et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation // Circulation. - 1992. - Vol. 86. - P. 1415-1420.
366.Murgatroyd F.D., Slade A.K., Sopher S.M. et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 13471353.
367.Lévy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation // J. Am. Coll. Cardiol. - 1997. - Vol. 29. - P. 750-755.
368.Santini M., Pandozi C., Colivicchi F. et al. Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration // Eur. Heart J. - 2002. - Vol. 21. -
P. 848-855.
369.Andersen H.R., Nielsen J.C., Thomsen P.E.B. et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome // Lancet. - 1997. - Vol. 350. - P. 1210-1216.
370.Connolly S.J., Kerr C.R., Gent M. et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators // N. Engl. J. Med. - 2000. - Vol. 342. - P. 1385-1391.
371.Lamas G.A., Lee K.L., Sweeney M.O. et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction // N. Engl. J. Med. - 2002. - Vol. 346. - P. 1854-1862.
372.Toff W.D., Camm A.J., Skehan J.D. United Kingdom Pacing and Cardiovascular Events Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block // N. Engl. J. Med. - 2005. - Vol. 353. - P. 145-155.
373.Healey J.S., Toff W.D., Lamas G.A. et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data // Circulation. -
2006. - Vol. 114. - P. 11-17.
374.The DAVID Trial Investigators. Dual-Chamber Pacing or Ventricular Backup Pacing in Patients with an Implantable Defibrillator (DAVID) Trial // JAMA. - 2002. - Vol. 288. - P. 3115-3123.
375.Sweeney M.O., Bank A.J., Nsah E. et al. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease // N. Engl. J. Med. - 2007. - Vol. 357. - P. 1000-1008.
376.Duytschaever M., Danse P., Eysbouts S. et al. Is there an optimal pacing site to prevent atrial fibrillation? - P. an experimental study in the chronically instrumented goat // J. Cardiovasc. Electrophysiol. - 2002. - Vol. 13. - P. 1264-1271.
377.Savelieva I., Camm A.J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? // J. Interv. Card Electrophysiol. - 2003. -
Vol. 8. - P. 103-115.
378.Padeletti L., Pürerfellner H., Adler S.W. et al. Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia // J. Cardiovasc. Electrophysiol. - 2003. - Vol. 14. - P. 1189-1195.
379.Saksena S., Prakash A., Ziegler P. et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy // J. Am. Coll. Cardiol. - 2002. - Vol. 40. -
P. 1140-1150.
380.Hoffmann E., Sulke N., Edvardsson N. et al. Atrial Fibrillation Therapy Trial Investigators. New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features // Circulation. - 2006. - Vol. 113. - P. 1933-1941.
381.Mont L., Ruiz-Granell R., Martinez J.G. et al. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial // Euro PACE. - 2008. - Vol. 10. - P. 28-34.
382.Camm A.J., Sulke N., Edvardsson N. et al. AFTherapy Investigators. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study // Euro PACE. -
2007. - Vol. 9. - P. 1110-1118.
383.Carlson M., Ip J., Messenger J. et al. Atrial Dynamic Overdrive Pacing Trial (ADOPT) Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 627-633.
384.Gold M., Hoffmann E. The impact of atrial prevention pacing on AF burden: Primary results of the study for atrial fibrillation (SAFARI trial) // Euro PACE. - 2006. - Vol. 8. - P. 222-223.
385.Knight B.P., Gersh B.J., Carlson MD, et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society // Circulation. - 2005. - Vol. 111. - P. 240243.
386.Lee M.A., Weachter R., Pollak S. et al. ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias // J. Am. Coll. Cardiol. - 2003. -
Vol. 41. - P. 1926-1932.
387.Geller J.C., Reek S., Timmermans C. et al. Treatment of atrial fibrillation with an implantable atrial defibrillator--long term results // Eur. Heart J. - 2003. - Vol. 24. - P. 2083-2089.
388.Dosdall D.J., Ideker R.E. Intracardiac atrial defibrillation // Heart Rhythm. - 2007. - Vol. 4. (3. Suppl): S51-S56.
389.Friedman P.A., Dijkman B., Warman E.N. et al. for the Worldwide Jewel AF Investigators. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients // Circulation. - 2001. - Vol. 104. - P. 1023-1028.
390.Boriani G., Diemberger I., Biffi M. et al. How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint // Pacing Clin. Electrophysiol. - 2007. - Vol. 30. - P. 422433.
391.Camm A.J., Savelieva I. Rationale and patient selection for ‘hybrid’ drug and device therapy in atrial and ventricular arrhythmias //
J. Interv. Card. Electrophysiol. - 2003. - Vol. 9. - P. 207-214.
392.Waldo A.L., Feld G.K. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 779-786.
393.Govindan M., Catanchin A., Camm A.J. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation // J. Cardiovasc. Pharmacol. - 2008. - Vol. 52. - P. 210221.
394.Wood M.A., Brown-Mahoney C., Kay G.N. et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis // Circulation. - 2000. - Vol. 101. - P. 1138-1144.
395.Ozcan C., Jahangir A., Friedman P.A. et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation // N. Engl. J. Med. - 2001. - Vol. 344. - P. 1043-1051.
396.Flaker G.C., Blackshear J.L., McBride R. et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators // J. Am. Coll. Cardiol. -
1992. - Vol. 20. - P. 527-532.
397.Tse H.F., Lau C.P. Long-term effect of right ventricular pacing on myocardial perfusion and function // J. Am. Coll. Cardiol. - 1997. - Vol. 29. - P. 744-749.
398.Williamson B.D., Man K.C., Daoud E. et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation // N. Engl. J. Med. - 1994. - Vol. 331. -
P. 910-917.
399.Feld G.K., Fleck R.P., Fujimura O. et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation // Circulation. - 1994. - Vol. 90. - P. 2299-2307.
400.Upadhyay G.A., Choudhry N.K., Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies // J. Am. Coll. Cardiol. - 2008. - Vol. 52. -
P. 1239-1246.
401.Doshi R.N., Daoud E.G., Fellows C. et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) // J. Cardiovasc. Electrophysiol. - 2005. - Vol. 16. - P. 1160-1165.
402.Ferreira A.M., Adragao P., Cavaco D.M. et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation // Euro PACE. - 2008. - Vol. 10. - P. 809-815.
403.Gasparini M., Auricchio A., Metra M. et al. Multicentre Longi-tudinal Observational Study (MILOS) Group. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation // Eur. Heart J. - 2008. - Vol. 29. -
P. 1644-1652.
404.Padeletti L., Muto C., Maounis T. et al. Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group. Atrial fibrillation in recipients of cardiac resynchronization therapy device. - P. 1-year results of the randomized MASCOT trial // Am. Heart J. - 2008. - Vol. 156. - P. 520526.
405.Haissaguerre M., Gencel L., Fischer B. et al. Successful catheter ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. - 1994. - Vol. 5. - P. 1045-1052.
406.Allessie M.A., Boyden P.A., Camm A.J. et al. Pathophysiology and prevention of atrial fibrillation // Circulation. - 2001. - Vol. 103. - P. 769-777.
407.Jais P., Haissaguerre M., Shah D.C. et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation // Circulation. -
1997. - Vol. 95. - P. 572-576.
408.Chen S.A., Hsieh M.H., Tai C.T. et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation // Circulation. - 1999. - Vol. 100. - P. 1879-1886.
409.Ho S.Y., Cabrera J.A., Tran V.H. et al. Architecture of the pulmonary veins: relevance to radiofrequency ablation // Heart. - 2001. - Vol. 86. - P. 265-270.
410.Hassink R.J., Aretz H.T., Ruskin J. et al. Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation // J. Am. Coll. Cardiol. - 2003. -
Vol. 42. - P. 1108-1114.
411.Jais P., Hocini M., Macle L., et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation // Circulation. - 2002. - Vol. 106. - P. 2479-2485.
412.Sanchez J.E., Plumb V.J., Epstein A.E. et al. Evidence for longitudinal and transverse fiber conduction in human pulmonary veins: relevance for catheter ablation // Circulation. - 2003. - Vol. 108. -
P. 590-597.
413.Takahashi S.X., Mittman S., Colecraft H.M. Distinctive modulatory effects of five human auxiliary beta2. subunit splice variants on L-type calcium channel gating // Biophys. J. - 2003. - Vol. 84. - P. 30073021.
414.Ouyang F., Bansch D., Ernst S. et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation // Circulation. - 2004. - Vol. 110. - P. 2090-2096.
415.Haissaguerre M., Shah D.C., Jais P. et al. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation // Am. J. Cardiol. - 2000. -
Vol. 86. (9A). - P. 9K-19K.
416.Haissaguerre M., Shah D.C., Jais P. et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins // Circulation. -
2000. - Vol. 102. - P. 2463-2465.
417.Oral H., Knight B.P., Tada H. et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation // Circulation. - 2002. - Vol. 105. - P. 1077-1081.
418.Mansour M., Ruskin J., Keane D. Efficacy and safety of segmental ostial versus circumferential extraostial pulmonary vein isolation for atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2004. - Vol. 15. -
P. 532-537.
419.Chen J., Hoff P.I., Erga K.S. et al. A clinical study of patients with and without recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation // Pacing Clin Electrophysiol. - 2005. - Vol. 28 (Suppl. 1). - Р. S86-S89.
420.Yamada T., Murakami Y., Okada T. et al. Incidence, location, and cause of recovery of electrical connections between the pulmonary veins and the left atrium after pulmonary vein isolation // Euro PACE.
-
2006. - Vol. 8. - P. 182-188.
421.Nilsson B., Chen X., Pehrson S. et al. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy // Am. Heart J. - 2006. - Vol. 152. - P. 537. e531-538.
422.Marrouche N.F., Martin D.O., Wazni O. et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications // Circulation. - 2003. - Vol. 107. - P. 2710-2716.
423.Arentz T., Weber R., Burkle G. et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study // Circulation. - 2007. -
Vol. 115. - P. 3057-3063.
424.Ouyang F., Antz M., Ernst S. et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique // Circulation. - 2005. - Vol. 111. - P. 127-135.
425.Ouyang F., Ernst S., Chun J. et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique // Circulation. - 2005. - Vol. 112. - P. 3038-48.
426.Haissaguerre M., Sanders P., Hocini M. et al. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome // Circulation. - 2004. - Vol. 109. - P. 3007-3013.
427.Haissaguerre M., Sanders P., Hocini M. et al. Pulmonary veins in the substrate for atrial fibrillation: the ‘venous wave’ hypothesis // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 2290-2292.
428.Pappone C., Rosanio S., Oreto G. et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation // Circulation. - 2000. - Vol. 102. - P. 26192628.
429.Hocini M., Sanders P., Jais P. et al. Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins // Eur. Heart J. - 2005. - Vol. 26. - P. 696-704.
430.Pappone C., Manguso F., Vicedomini G. et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach // Circulation. - 2004. - Vol. 110. -
P. 3036-3042.
431.Gerstenfeld E.P., Callans D.J., Dixit S. et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation // Circulation. - 2004. - Vol. 110. - P. 1351-1357.
432.Verma A., Kilicaslan F., Pisano E. et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction // Circulation. - 2005. - Vol. 112. - P. 627-635.
433.Ernst S., Ouyang F., Lober F. et al. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: an electroanatomic study // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 1271-1282.
434.Jais P., Shah D.C., Haissaguerre M. et al. Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation // Am. J. Cardiol. - 1999. - Vol. 84. (9A). - P. 139R-146R.
435.Jais P., Hocini M., Hsu L.F. et al. Technique and results of linear ablation at the mitral isthmus // Circulation. - 2004. - Vol. 110. - P. 2996-3002.
436.Willems S., Klemm H., Rostock T. et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison // Eur. Heart J. - 2006. - Vol. 27. - P. 2871-2878.
437.Takahashi Y., Jais P., Hocini M. et al. Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation //
J. Cardiovasc. Electrophysiol. - 2005. - Vol. 16. - P. 1104-1107.
438.Sanders P., Jais P., Hocini M. et al. Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation // Heart Rhythm. - 2004. - Vol. 1. - P. 176-184.
439.Pappone C., Oral H., Santinelli V. et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation // Circulation. - 2004. - Vol. 109. - P. 2724-2726.
440.Mesas C.E., Pappone C., Lang C.C. et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 1071-1079.
441.Chae S., Oral H., Good E. et al. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence // J. Am. Coll. Cardiol. - 2007. - Vol. 50. - P. 1781-1787.
442.Satomi K., Bansch D., Tilz R. et al. Left atrial and pulmonary vein macroreentrant tachycardia associated with double conduction gaps: a novel type of man-made tachycardia after circumferential pulmonary vein isolation // Heart Rhythm. - 2008. - Vol. 5. - P. 43-51.
443.Oral H., Chugh A., Lemola K. et al. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study // Circulation. - 2004. -
Vol. 110. - P. 2797-2801.
444.Karch M.R., Zrenner B., Deisenhofer I. et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2. current ablation strategies // Circulation.
-
2005. - Vol. 111. - P. 2875-2880.
445.Nademanee K., McKenzie J., Kosar E. et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 2044-2053.
446.Nademanee K., Schwab M.C., Kosar E.M. et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 843-849.
447.Rostock T., Rotter M., Sanders P. et al. High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation // Heart Rhythm. - 2006. - Vol. 3. - P. 27-34.
448.Estner H.L., Hessling G., Ndrepepa G. et al. Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation // Am. J. Cardiol. - 2008. - Vol. 101. - P. 332-337.
449.Lin Y.J., Tai C.T., Kao T. et al. Consistency of complex fractionated atrial electrograms during atrial fibrillation // Heart Rhythm. - 2008. - Vol. 5. - P. 406-412.
450.Crawford T.C., Wimmer A., Dey S. et al. Mechanism of recurrence after radiofrequency catheter ablation of atrial fibrillation guided by complex fractionated atrial electrograms // J. Interv. Card. Electrophysiol. - 2008. - Vol. 21. - P. 27-33.
451.Danik S., Neuzil P., d’Avila A. et al. Evaluation of catheter ablation of periatrial ganglionic plexi in patients with atrial fibrillation // Am. J. Cardiol. - 2008. - Vol. 102. - P. 578-583.
452.Hou Y., Scherlag B.J., Lin J. et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation // J. Am. Coll. Cardiol. - 2007. - Vol. 50. - P. 61-68.
453.Lemery R., Birnie D., Tang A.S. et al. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation // Heart Rhythm. - 2006. - Vol. 3. - P. 387-396.
454.Tamborero D., Mont L., Nava S. et al. Incidence of pulmonary vein stenosis in patients submitted to atrial fibrillation ablation: a comparison of the Selective Segmental Ostial Ablation vs the Circumferential Pulmonary Veins Ablation // J. Interv. Card. Electrophysiol. - 2005. -
Vol. 14. - P. 21-25.
455.Reddy V.Y., Malchano Z.J., Holmvang G. et al. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 22022213.
456.Richmond L., Rajappan K., Voth E. et al. Validation of computed tomography image integration into the EnSite NavX mapping system to perform catheter ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2008. - Vol. 19. - P. 821-827.
457.Kistler P.M., Rajappan K., Jahngir M. et al. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2006. - Vol. 17. - P. 1093-1101.
458.Bae KT, Hong C, Whiting BR. Radiation dose in multidetector row computed tomography cardiac imaging // J. Magn. Reson. Imaging. -
2004. - Vol. 19. - P. 859-863.
459.Gerber T.C., Kuzo R.S., Morin R.L. Techniques and parameters for estimating radiation exposure and dose in cardiac computed tomography // Int. J. Cardiovasc. Imaging. - 2005. - Vol. 21. - P. 165-176.
460.Allgayer C., Zellweger M.J., Sticherling C. et al. Optimization of imaging before pulmonary vein isolation by radiofrequency ablation: breath-held ungated versus ECG/breath-gated MRA // Eur. Radiol. -
2008. - Vol. 18. - P. 2879-2884.
461.Scanavacca M.I., D’Avila A., Parga J. et al. Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2004. - Vol. 15. - P. 960-962.
462.Ghia K.K., Chugh A., Good E. et al. A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation // J. Interv. Card. Electrophysiol. - 2009. - Vol. 24. -
P. 33-36.
463.Lemola K., Sneider M., Desjardins B. et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation // Circulation. - 2004. - Vol. 110. -
P. 3655-3660.
464.Kottkamp H., Piorkowski C., Tanner H. et al. Topographic variability of the esophageal left atrial relation influencing ablation lines in patients with atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2005. -
Vol. 16. - P. 146-150.
465.Daoud E.G., Hummel J.D., Houmsse M. et al. Comparison of computed tomography imaging with intraprocedural contrast esophagram: implications for catheter ablation of atrial fibrillation // Heart Rhythm. - 2008. - Vol. 5. - P. 975-980.
466.Cummings J.E., Schweikert R.A., Saliba W.I. et al. Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium // Circulation. - 2005. - Vol. 112. - P. 459-464.
467.Aryana A., Heist E.K., D’Avila A. et al. Pain and anatomical locations of radiofrequency ablation as predictors of esophageal temperature rise during pulmonary vein isolation // J. Cardiovasc. Electrophysiol. -
2008. - Vol. 19. - P. 32-38.
468.Hornero F., Berjano E.J. Esophageal temperature during radiofrequency-catheter ablation of left atrium: a three-dimensional computer modeling study // J. Cardiovasc. Electrophysiol. - 2006. - Vol. 17. -
P. 405-410.
469.Robbins I.M., Colvin E.V., Doyle T.P. et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation // Circulation. - 1998. - Vol. 98. - P. 1769-1775.
470.Ernst S., Ouyang F., Goya M. et al. Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease // J. Cardiovasc. Electrophysiol. - 2003. - Vol. 14. -
P. 366-370.
471.Nilsson B., Chen X., Pehrson S. et al. Acute fatal pulmonary vein occlusion after catheter ablation of atrial fibrillation // J. Interv. Card. Electrophysiol. - 2004. - Vol. 11. - P. 127-130.
472.Packer D.L., Keelan P., Munger T.M. et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation // Circulation. - 2005. - Vol. 111. -
P. 546-554.
473.Dill T., Neumann T., Ekinci O. et al. Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging // Circulation. - 2003. - Vol. 107. - P. 845-850.
474.Schneider C., Ernst S., Bahlmann E. et al. Transesophageal echocardiography: a screening method for pulmonary vein stenosis after catheter ablation of atrial fibrillation // Eur. J. Echocardiogr. - 2006. - Vol. 7. - P. 447-456.
475.Sanchez-Quintana D., Cabrera J.A., Climent V. et al. How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists // J. Cardiovasc. Electrophysiol. - 2005. - Vol. 16. -
P. 309-313.
476.Sacher F., Jais P., Stephenson K. et al. Phrenic nerve injury after catheter ablation of atrial fibrillation // Indian. Pacing Electrophysiol. J. -
2007. - Vol. 7. - P. 1-6.
477.Hsu L.F., Jais P., Hocini M. et al. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation // Pacing Clin. Electrophysiol. - 2005. - Vol. 28(Suppl.1): S106-S109.
478.Bertaglia E., Zoppo F., Tondo C. et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety // Heart Rhythm. - 2007. - Vol. 4. - P. 1265-1271.
479.Spragg D.D., Dalal D., Cheema A. et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors // J. Cardiovasc. Electrophysiol. - 2008. - Vol. 19. - P. 627-631.
480.Cappato R., Calkins H., Chen S.A. et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation // J. Am. Coll. Cardiol. - 2009. - Vol. 53. - P. 1798-1803.
481.Noheria A., Kumar A., Wylie J.V. Jr. et al. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review // Arch. Intern. Med. - 2008. - Vol. 168. - P. 581-586.
482.Camm A.J., Savelieva I. Atrial fibrillation: a4. study - proof of concept // Nat. Rev. Cardiol. - 2009. - Vol. 6. - P. 332-334.
483.Krittayaphong R., Raungrattanaamporn O., Bhuripanyo K. et al.
A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation // J. Med. Assoc. Thai. - 2003. - Vol. 86(Suppl.1). - S8-S16.
484.Wazni O.M., Marrouche N.F., Martin D.O. et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial // JAMA. - 2005. - Vol. 293. -
P. 2634-2640.
485.Stabile G., Bertaglia E., Senatore G. et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study) // Eur. Heart J. - 2006. - Vol. 27. - P. 216-221.
486.Oral H., Pappone C., Chugh A. et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation // N. Engl. J. Med. - 2006. - Vol. 354. - P. 934-941.
487.Pappone C., Augello G., Sala S. et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study // J. Am. Coll. Cardiol.
-
2006. - Vol. 48. - P. 2340-2347.
488.Jaïs P., Cauchemez B., Macle L. et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation // Circulation. - 2008. - Vol. 118. - P. 2498-2505.
489.Forleo G.B., Mantica M., De Luca L. et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy // J. Cardiovasc. Electrophysiol. - 2009. - Vol. 20. - P. 22-28.
490.Wright M., Haissaguerre M, Knecht S. et al. State of the art: catheter ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. - 2008. -
Vol. 19. - P. 583-592.
491.Haissaguerre M., Hocini M., Sanders P. et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias // J. Cardiovasc. Electrophysiol. - 2005. - Vol. 16. - P. 1138-1147.
492.Chen M.S., Marrouche N.F., Khaykin Y. et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 10041009.
493.Tondo C., Mantica M., Russo G. et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function // Pacing Clin. Electrophysiol. - 2006. - Vol. 29. - P. 962-970.
494.Gentlesk P.J., Sauer W.H., Gerstenfeld E.P. et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation //
J. Cardiovasc. Electrophysiol. - 2007. - Vol. 18. - P. 9-14.
495.Efremidis M., Sideris A., Xydonas S. et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling // Hellenic. J. Cardiol. - 2008. - Vol. 49. - P. 19-25.